Cloning and characterization of human and mouse telomerase RNA gene promoter sequences

Oncogene

Volumn 16, Issue 10, 1998, Pages 1345-1350

  Zhao, Jiang Qin ^a   Hoare, Stacey F ^a   McFarlane, Robert ^b   Muir, Sharon ^a   Parkinson, E Kenneth ^b   Black, Donald M ^b   Keith, W Nicol ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

Gene expression; Gene promoter; Gene transcription; hTR; Telomerase; terc

Indexed keywords

MESSENGER RNA; TELOMERASE;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; CPG ISLAND; DNA FLANKING REGION; DNA METHYLATION; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE SEQUENCE; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSCRIPTION REGULATION;

ANIMALIA; MAMMALIA;

EID: 0032510333     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201892     Document Type: Article

References (48)

1. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S and Greider CW. (1996). Cancer Res., 56, 645-650.
2. Baylin SB, Makos M, Wu J, Yen RW, De BA, Vertino P and Nelkin BD. (1991). Cancer Cells, 3, 383-390.
3. Bestilny LJ, Brown CB, Miura Y, Robertson LD and Riabowol KT. (1996). Cancer Res., 56, 3796-3802.
4. Bird AP. (1996). Cancer Sur., 28, 87-101
5. Blasco MA, Funk W, Villeponteau B and Greider CW. (1995). Science, 269, 1267-1270.
6. Blasco MA, Lee H, Hande MP, Samper E, Lansdorp PM, DePinho RA and Greider CW. (1997). Cell, 91, 25-34.
7. Blasco MA, Rizen M, Greider CW and Hanaham D. (1996). Nature Genetics, 12, 200-204.
8. Bodnar AG, Kim NW, Effros RB and Chiu CP. (1996). Exper. Cell Res., 228, 58-64.
9. Broccoli D, Chong L, Oelmann S, Fernald AA, Marziliano N, Van SB, Kipling D, Le BMM and De LT. (1997). Human Mol. Genet., 6, 69-76.
10. Broccoli D, Godley LA, Donehower LA, Varmus HE and De LT. (1996). Mol. Cell. Biol., 16, 3765-3772.
11. Bryan TM, Marusic L, Bacchetti S, Namba M and Reddel RR. (1997). Human Mol. Genet., 6, 921-926.
12. Cai W, Hu L and Foulkes JG. (1996). Curr. Opin. Biotechnol., 7, 608-615.
13. Campisi J. (1997). Euro. J. Cancer Part A, 33, 703-709.
14. Cheng AJ, Liao SK, Chow SE, Chen JK and Wang TC. (1997). Biochem. Biophys. Res. Comm., 237, 438-444.
15. Connors TA. (1995). Gene Therapy, 2, 702-709.
16. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW and Villeponteau B. (1995). Science, 269, 1236-1241.
17. Galang CK, Der CJ and Hauser CA. (1994). Oncogene, 9, 2913-2921.
18. Gardiner-Garden M and Frommer M. (1987). J. Molec. Biol., 196, 261-282.
19. Holt SE, Wright WE and Shay JW. (1997). Euro. J. Cancer Part A, 33, 761-766.
20. Irving J, Feng J, Wistrom C, Pikaart M and Villeponteau B. (1992). Exper. Cell Res., 202, 161-166.
21. Kim NW. (1997). Eur. J. Cancer Part A, 33, 781-786.
22. Kipling D. (1997a). Hum. Mol. Genet., 6, 1999-2004.
23. Kipling D. (1997b). Eur. J. Cancer Part A, 33, 792-800.
24. Kuniyasu H, Domen T, Hamamoto T, Yokozaki H, Yasui W, Tahara H and Tahara E. (1997). Jap. J. Cancer Res., 88, 103-107.
25. Laird PW and Jaenisch R. (1996). Annu. Rev. Genet., 30, 44-464
26. Li H, Zhao LL, Funder JW and Liu JP. (1997). J. Biol. Chem., 272, 16729-16732.
27. Mandal M and Kumar R. (1997). J. Biol. Chem., 272, 14183-14187.
28. Miller N and Whelan J. (1997). Human Gene Ther., 8, 803-815.
29. Morin GB. (1997). Eur. J. Cancer Part A, 33, 750-760.
30. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB and Cech TR. (1997). Science, 277, 955-959.
31. Norrback KF and Roos G. (1997). Eur. J. Cancer Part A, 33, 774-780.
32. Pan C, Xue BH, Ellis TM, Peace DJ and Diaz MO. (1997). Exper. Cell Res., 231, 346-353.
33. Peterson MG and Baichwal VR. (1993). Trends in Biotech., 11, 11-18.
34. Prowse KR and Greider CW. (1995). Proc. Nat. Acad. Sci. USA, 92, 4818-4822.
35. Riabowol K, Schiff J and Gilman MZ. (1992). Proc. Nat. Acad. Sci. USA, 89, 157-161.
36. Seshadri T and Campisi J. (1990). Science, 247, 205-209.
37. Sharma S, Raymond E, Soda H, Sun D, Hilsenbeck SG, Sharma A, Izbicka E, Windle B and Von Hoff DD. (1997). Ann. Oncol., 8, 1063-1074.
38. Shay JW and Bacchetti S. (1997). Eur. J. Cancer Part A, 33, 787-791.
39. Soder AI, Going JJ, Kaye SB and Keith WN. (1997a). Oncogene, in press.
40. Soder AI, Hoare SF, Muir S, Going JJ, Parkinson EK and Keith WN. (1997b). Oncogene, 14, 1013-1021.
41. Soder AI, Hoare SF, Muire S, Balmain A, Parkinson EK and Keith WN. (1997c). Genomics, 41, 293-294.
42. Tenen DG, Hromas R, Licht JD and Zhang DE. (1997). Blood, 90, 489-519.
43. Vertino PM, Issa JP, Pereira-Smith OM and Baylin SB. (1994). Cell Growth Differ., 5, 1395-1402.
44. Wasylyk C, Maira SM, Sobieszczuk P and Wasylyk B. (1994). Oncogene, 9, 3665-3673.
45. Wellinger RJ and Sen D. (1997). Eur. J. Cancer Part A, 33, 735-749.
46. Wilson VL and Jones PA. (1983). Science, 220, 1055-1057.
47. Wright WE, Piatyszek MA, Rainey WE, Byrd W and Shay JW. (1996). Dev. Genet., 18, 173-179.
48. Zakian VA. (1997). Cell, 91, 1-3.